Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report
Abstract Background Emicizumab is a novel prophylactic medication used to treat patients with hemophilia A. It is indicated to minimize the frequency of bleeding episodes and the severity of serious bleeding in patients with hemophilia A utilizing inhibitors. However, some cases of bleeding episodes...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2023-02-01
|
| coleção: | Journal of Medical Case Reports |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13256-023-03783-7 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|